SB 6

  • California Senate Bill
  • 2025-2026 Regular Session
  • Introduced in Senate Dec 02, 2024
  • Passed Senate Jun 03, 2025
  • Assembly
  • Governor

Controlled substances: xylazine.

Abstract

Existing law, the California Uniform Controlled Substances Act, categorizes controlled substances into 5 schedules and places the greatest restrictions on those substances contained in Schedule I. Under existing law, the substances in Schedule I are deemed to have a high potential for abuse and no accepted medical use while substances in Schedules II through V are substances that have an accepted medical use, but have the potential for abuse. Existing law restricts the prescription, furnishing, possession, sale, and use of controlled substances, and makes a violation of those laws a crime, except as specified. Existing law defines drug paraphernalia and prohibits, among other things, the manufacture, sale, and possession, as specified, of drug paraphernalia. Existing law excludes from these prohibitions any testing equipment that is designed, marketed, used, or intended to be used to analyze a substance for the presence of fentanyl, ketamine, gamma hydroxybutyric acid, or any analog of fentanyl. This bill would add xylazine to the list of Schedule III substances, as specified. If an animal drug containing xylazine that has been approved under the federal Food, Drug and Cosmetic Act is not available for sale in California, the bill would create an exception for a substance that is intended to be used to compound an animal drug, as specified. The bill would exclude from the prohibitions on paraphernalia any testing equipment to analyze a substance for the presence of xylazine. By creating a new crime, the bill would impose a state-mandated local program. The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement. This bill would provide that no reimbursement is required by this act for a specified reason.

Bill Sponsors (1)

Votes


Actions


Aug 29, 2025

Assembly

August 29 hearing: Held in committee and under submission.

Jul 16, 2025

Assembly

July 16 set for first hearing. Placed on APPR. suspense file.

Jul 02, 2025

Assembly

From committee: Do pass and re-refer to Com. on APPR. (Ayes 9. Noes 0.) (July 1). Re-referred to Com. on APPR.

  • Committee-Passage
  • Committee-Passage-Favorable
  • Referral-Committee
Com. on APPR.

Jun 09, 2025

Assembly

Referred to Com. on PUB. S.

  • Referral-Committee
Com. on PUB. S.

Jun 04, 2025

Assembly

In Assembly. Read first time. Held at Desk.

Jun 03, 2025

Senate

Read third time. Passed. (Ayes 38. Noes 0. Page 1472.) Ordered to the Assembly.

May 23, 2025

Senate

From committee: Do pass. (Ayes 6. Noes 0. Page 1187.) (May 23).

Senate

Read second time. Ordered to third reading.

May 16, 2025

Senate

Set for hearing May 23.

Apr 07, 2025

Senate

April 7 hearing: Placed on APPR. suspense file.

Mar 28, 2025

Senate

Set for hearing April 7.

Mar 25, 2025

Senate

From committee: Do pass and re-refer to Com. on APPR. (Ayes 6. Noes 0. Page 532.) (March 25). Re-referred to Com. on APPR.

  • Committee-Passage
  • Committee-Passage-Favorable
  • Referral-Committee
Com. on APPR.

Mar 07, 2025

Senate

Set for hearing March 25.

Jan 29, 2025

Senate

Referred to Com. on PUB. S.

  • Referral-Committee
Com. on PUB. S.

Dec 03, 2024

Senate

From printer. May be acted upon on or after January 2.

Dec 02, 2024

Senate

Introduced. Read first time. To Com. on RLS. for assignment. To print.

Bill Text

Bill Text Versions Format
SB6 HTML
12/02/24 - Introduced PDF

Related Documents

Document Format
03/21/25- Senate Public Safety PDF
04/04/25- Senate Appropriations PDF
05/24/25- Sen. Floor Analyses PDF
06/30/25- Assembly Public Safety PDF
07/14/25- Assembly Appropriations PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the California State Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.